COST-EFFECTIVENESS OF THE USE OF TESTING THE ACETYLARY STATUS OF PATIENTS WITH CHEMICAL EYE BURNS
Keywords:
cost effectiveness, standardized and individualized approaches, chemical burns of eyes, phenotype of acetylationAbstract
The study was conducted on 150 patients with chemical burns of the eyes who were hospitalized in the republican clinical ophthalmological hospital of the ministry of health of the republic of Uzbekistan. The calculation of economic efficiency was carried out according to Yunkerov V.I., Grigoryev S.G. (2002) in the modification of Mirsaidov E.M. and using methods for assessing the economic effectiveness of the compared options. According to the results of the study, it was found that an individualized approach to the management of patients with chemical burns of the eyes gives greater economic efficiency than a standardized approach to the management of such patients, considering the costs of determining their acetylar status, and the average cost per patient was 299,720 UZS; the method of individualization of patients with determination of their acetylation phenotype is economically less expensive and easy to perform compared to the method of determining human leukocyte antigens (HLa) histocompatibility and the savings when comparing the cost of carrying out these test methods was 413000 UZS per single study in favor of the method of determining acetylation phenotype.
References
Temporary recommendations on the management of patients infected with coronavirus
infection COVID-19, Akilov K.A., Tuychiev L.N., Jaewook Choi, Ibadova G.A. et al.
//Recommendations for physicians. -Tashkent, 2020, 84 p;
Duganov M.D. Evaluation of the effectiveness of health expenditures at the regional and municipal levels / M.D. Duganov. - MOSCOW: IEP, 2007. – p.112.;
Ermakov S.P., Duganov M.D., Makeev A.N., Kolinko A.A. Financial macroanalysis in public health: guidelines for use at regional and municipal levels / M. - 2000. – p.238;
Efimenko, S.A. Social Aspects of the Doctor-Patient Relations / Sociology of Medicine. 2006. № 1. - pp. 9-14.
Kolosnitsina M.G., Sheiman I.M., Shishkina S.V. Economics of health care / Moscow: GU HSE, 2009. – p. 476.).
Kucherenko V.Z., Razlivinskikh L.P., Martynenko V.F. Methodological approaches to the evaluation of the activity of medical and preventive institutions: monitoring indicators, indicators, criteria, definitions / Health Economics: Journal for health organizers / M., 2006. №8. pp. 29 - 37;
Movchan K.A., Glushanko V.S., Plish A.V. Techniques of calculations of the efficiency of medical technologies in health care / Instruction for use / МЗ of the Republic of Belarus, Vitebsk, 2003, - 27 p. 8.
Reshetnikova, A.V. Economy of Public Health / A.V. Reshetnikova. - Moscow: GEOTARMedia, 2007. – p.272.
Shamshurina, N.G. Indices of socio-economic effectiveness in Public Health / N.G. Shamshurina. - MOSCOW: MTSFER, 2005. – p.318.
Yunkerov V.I., Grigoriev S.G. Mathematical and statistical data processing of medical research. Sankt Peterburg, 2002. – p. 266.
Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J. Antimicrobial Agents. 2020 Mar 12:105938. doi: 10.1016/j.ijantimicag.2020.105938.;
Fan HH, Wang LQ, Liu WL, An XP, Liu ZD, He XQ, Song LH, Tong YG. Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019- novel coronavirus (2019-nCoV) related coronavirus model. Chin Med J (Engl). 2020 Mar 6. doi: 10.1097/CM9.0000000000000797;
Granata A. V., Hillman A. L. Using cost-effectiveness analysis to make optimal decisions / A. V. Granata, // Ann а ls of Internal Medicine. – 1998. – 128. – P. 56 – 63
TerasaсkiP.L., Meclelland J.D. Microdroplet assay of human serum cytotoxins //Nature.-1964.- Vol.204.-P.998-1000
Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, Wang J, Qin Y, Zhang X, Yan X, Zeng X, Zhang S. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The experience of clinical immunologists from China
